- Recon: Novo sues Lilly over weight-loss drug ads; Gilead, Merck say HIV pill keeps HIV suppressed in two Phase 3 trialsWelcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.raps · 8d ago↗ source
- FDA cites companies for CGMP violations, informed consent failureThe US Food and Drug Administration has issued warning letters to several drug makers for failing to meet its current good manufacturing practices (CGMP) requirements and a company for failing to s…raps · 8d ago↗ source
- European Commission publishes guideline on transparency obligations under AI ActThe European Commission on Monday published new guidelines to assist providers and deployers of artificial intelligence (AI) systems in fulfilling transparency obligations under the EU’s AI Act, in…